On Monday, Following Stocks were among the “Top 100 Gainers” of U.S. Stock Market: Huntsman Corporation (NYSE:HUN), Southwestern Energy Co. (NYSE:SWN), Goodrich Petroleum Corp. (NYSE:GDP), DURECT Corporation (NASDAQ:DRRX)
Huntsman Corporation (NYSE:HUN), with shares gained 3.25%, closed at $21.95.
Southwestern Energy Co. (NYSE:SWN), with shares jumped 3.18%, settled at $23.03.
Goodrich Petroleum Corp. (NYSE:GDP), with shares climbed 6.40%, and closed at $3.49.
DURECT Corporation (NASDAQ:DRRX), surged 6.38%, and closed at $2.
Latest NEWS regarding these Stocks are depicted underneath:
Huntsman Corporation (NYSE:HUN)
Formerly on March 19, Huntsman Corporation (HUN), declared that it has priced a €300 million in aggregate principal amount offering of senior notes due 2025 through its wholly owned partner, Huntsman International LLC. The Notes will carry an interest rate of 4.25% and will mature on April 1, 2025. The closing of the offering is predictable to occur on March 31, 2015, subject to the satisfaction of customary closing conditions. Huntsman intends to use the net proceeds from the offering to redeem a portion of its 8.625% Senior Subordinated Notes due 2021 and to pay associated accrued interest.
The Notes will not initially be registered under the Securities Act of 1933, as amended, or under any state securities law; and unless so registered, the Notes may not be offered or sold in the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws. The Notes are being offered only to qualified institutional buyers under Rule 144A and outside the United States in compliance with Regulation S under the Securities Act.
Huntsman Corporation, together with its auxiliaries, manufactures and sells differentiated organic and inorganic chemical products worldwide. The corporation operates in five segments: Polyurethanes, Performance Products, Advanced Materials, Textile Effects, and Pigments and Additives.
Southwestern Energy Co. (NYSE:SWN)
Southwestern Energy Co. (SWN), declared that it has executed a definitive contract with a private buyer to sell Southwestern Energy’s conventional oil and gas assets located in East Texas and the Arkoma Basin for about $218 million. The proceeds from the transaction will be used to reduce debt. The transaction is subject to customary closing conditions and is predictable to close in the second quarter of 2015.
“Combined with the already declared divestiture of our northeast Pennsylvania gathering system, this transaction achieves the net divestiture proceeds targeted as part of the attainment financing plan,” remarked Steve Mueller, Chairman and Chief Executive Officer of Southwestern Energy. “With the attainment financing now complete, we will continue our focus on extracting the long-term value from our premier assets for our shareholders for years to come.”
RBC Richardson Barr advised Southwestern in connection with this transaction.
Southwestern Energy Corporation, an independent energy corporation, engages in the exploration, development, and production of natural gas and oil in the United States. The corporation operates in two segments, Exploration, Development and Production; and Midstream Services.
Goodrich Petroleum Corp. (NYSE:GDP)
Formerly on March 12, Goodrich Petroleum Corp. (GDP), declared that it has closed its formerly confirmed offering of $100 million aggregate principal amount of 8% senior secured notes issued at par due 2018. Net proceeds from the offering totaled about $98 million. The Corporation intends to use the net proceeds from the offering to repay borrowings under its credit facility and for general corporate purposes.
Goodrich Petroleum Corporation, an independent oil and natural gas corporation, engages in the exploration, development, and production of oil and natural gas. The corporation holds interest in the Tuscaloosa Marine Shale located in southwest Mississippi and southeast Louisiana; the Eagle Ford Shale Trend located in South Texas; and the Haynesville Shale Trend in Northwest Louisiana and East Texas.
DURECT Corporation (NASDAQ:DRRX)
DURECT Corporation (DRRX), declared that it has initiated a multi-dose Phase 1 clinical trial of an oral formulation of DUR-928, the lead molecule in DURECT’s Epigenomic Regulator Program. DUR-928 is an endogenous, small-molecule, new chemical entity (NCE) that may have broad applicability in metabolic diseases such as nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). It may also play an important role in protecting against acute kidney injury (AKI) and other types of acute organ injury.
“Following the successful completion of our Phase 1 oral, single-dose study of DUR-928, we have now begun enrollment for a Phase 1 multiple-ascending-dose trial,” said James E. Brown, President and CEO of DURECT. “This trial will provide valuable information on multi-dose pharmacokinetics that will be important as we continue moving toward Phase 2 planned for next year.”
DURECT Corporation, a specialty pharmaceutical corporation, focuses on the development of pharmaceuticals products based on its proprietary drug formulations and delivery platform technologies in the United States, Europe, Japan, and internationally.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
